Literature DB >> 21099430

New molecular approaches in the diagnosis of acute diarrhea: advantages for clinicians and researchers.

Alfredo Guarino1, Antonietta Giannattasio.   

Abstract

PURPOSE OF REVIEW: To provide an update of the advantages of new-generation molecular diagnostics as regards acute diarrhea, and to evaluate how they can help clinicians and researchers diagnose this condition. RECENT
FINDINGS: Thanks to real-time polymerase chain reaction techniques, many enteropathogens can now be identified simultaneously within hours. Most techniques are based on amplification of specific nucleotide sequences. With high-resolution melting analyses, microarrays, and metagenomic analyses, multiple genomic sequences can be evaluated in a single sample; thus, a wide range of enteropathogens can be evaluated in one run. Molecular techniques have elucidated the role of major enteropathogens such as norovirus and bocavirus and their evolving epidemiology. They have revealed novel transmission routes, also in food-borne diarrhea outbreaks, and have opened the way to new therapies and preventive measures, as well as to surveillance of emerging rotavirus strains after vaccine introduction.
SUMMARY: Molecular approaches are best suited for epidemiologic purposes and for selected clinical conditions such as early identification of treatable agents in at-risk patients, rather than for cases requiring only oral rehydration. In the field of acute diarrhea, the major application of molecular techniques is the identification of novel agents of gastroenteritis and their epidemiology.

Entities:  

Mesh:

Year:  2011        PMID: 21099430     DOI: 10.1097/MOG.0b013e3283413750

Source DB:  PubMed          Journal:  Curr Opin Gastroenterol        ISSN: 0267-1379            Impact factor:   3.287


  13 in total

1.  Comparison of the BD MAX® Enteric Bacterial Panel assay with conventional diagnostic procedures in diarrheal stool samples.

Authors:  L Knabl; I Grutsch; D Orth-Höller
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-11-13       Impact factor: 3.267

2.  Single-copy quantification of HIV-1 in clinical samples.

Authors:  Ann Wiegand; Frank Maldarelli
Journal:  Methods Mol Biol       Date:  2014

3.  Comparison of the BD MAX enteric bacterial panel to routine culture methods for detection of Campylobacter, enterohemorrhagic Escherichia coli (O157), Salmonella, and Shigella isolates in preserved stool specimens.

Authors:  Neil W Anderson; Blake W Buchan; Nathan A Ledeboer
Journal:  J Clin Microbiol       Date:  2014-01-15       Impact factor: 5.948

Review 4.  Omics approaches in food safety: fulfilling the promise?

Authors:  Teresa M Bergholz; Andrea I Moreno Switt; Martin Wiedmann
Journal:  Trends Microbiol       Date:  2014-02-23       Impact factor: 17.079

5.  2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea.

Authors:  Andi L Shane; Rajal K Mody; John A Crump; Phillip I Tarr; Theodore S Steiner; Karen Kotloff; Joanne M Langley; Christine Wanke; Cirle Alcantara Warren; Allen C Cheng; Joseph Cantey; Larry K Pickering
Journal:  Clin Infect Dis       Date:  2017-11-29       Impact factor: 9.079

6.  Nonculture diagnostic tests for enteric diseases.

Authors:  Timothy F Jones; Peter Gerner-Smidt
Journal:  Emerg Infect Dis       Date:  2012-03       Impact factor: 6.883

Review 7.  Management of children with prolonged diarrhea.

Authors:  Antonietta Giannattasio; Alfredo Guarino; Andrea Lo Vecchio
Journal:  F1000Res       Date:  2016-02-23

Review 8.  Antibiotic treatment of acute gastroenteritis in children.

Authors:  Eugenia Bruzzese; Antonietta Giannattasio; Alfredo Guarino
Journal:  F1000Res       Date:  2018-02-15

9.  Use of BioFire FilmArray gastrointestinal PCR panel associated with reductions in antibiotic use, time to optimal antibiotics, and length of stay.

Authors:  Daisy Torres-Miranda; Hana Akselrod; Ryan Karsner; Alessandra Secco; Diana Silva-Cantillo; Marc O Siegel; Afsoon D Roberts; Gary L Simon
Journal:  BMC Gastroenterol       Date:  2020-07-29       Impact factor: 3.067

10.  Disrupted intestinal microbiota and intestinal inflammation in children with cystic fibrosis and its restoration with Lactobacillus GG: a randomised clinical trial.

Authors:  Eugenia Bruzzese; Maria Luisa Callegari; Valeria Raia; Sara Viscovo; Riccardo Scotto; Susanna Ferrari; Lorenzo Morelli; Vittoria Buccigrossi; Andrea Lo Vecchio; Eliana Ruberto; Alfredo Guarino
Journal:  PLoS One       Date:  2014-02-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.